Skip to main content
. 2021 Oct 15;11:710163. doi: 10.3389/fonc.2021.710163

Figure 3.

Figure 3

Anthracyclines-induced cardiotoxicity mechanisms and proposed biomarkers. Genes suggested contributing to anthracycline-induced cardiotoxicity risk include: genes active in anthracyclines biotransformation or transport, and genes active in cardiomyocytes vulnerability. The complex interaction between these genes products and the toxicity mechanisms is simplified here. ROS, Reactive Oxygen Species.